Join
Live feed
·
PRReleasevia Quantisnow
Vyant Bio Inc. logo

Vyant Bio Reports Second Quarter and First Half 2022 Results and Provides Strategic and Business Highlights

ByQuantisnow·Wall Street's wire, on your screen.
VYNT· Vyant Bio Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VYNT (Vyant Bio Inc.) and more on Quantisnow.